Nephro Care India Ltd
Incorporated in 2014, Nephro Care India Limited is a comprehensive treatment center located in Kolkata, offering a wide range of clinical and lifestyle solutions[1]
- Market Cap ₹ 459 Cr.
- Current Price ₹ 278
- High / Low ₹ 278 / 171
- Stock P/E 236
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 72.0 %
- ROE 132 %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| 1.82 | 3.42 | 17.09 | |
| 1.67 | 3.28 | 13.44 | |
| Operating Profit | 0.15 | 0.14 | 3.65 |
| OPM % | 8.24% | 4.09% | 21.36% |
| 0.01 | -0.01 | 0.00 | |
| Interest | 0.03 | 0.02 | 0.15 |
| Depreciation | 0.01 | 0.11 | 0.79 |
| Profit before tax | 0.12 | 0.00 | 2.71 |
| Tax % | 25.00% | 28.04% | |
| 0.09 | -0.01 | 1.94 | |
| EPS in Rs | 90.00 | -0.20 | 38.80 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 400% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 585% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 132% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Equity Capital | 0.01 | 0.50 | 0.50 |
| Reserves | 0.01 | 0.00 | 1.94 |
| 0.69 | 2.54 | 2.46 | |
| 0.42 | 1.60 | 3.40 | |
| Total Liabilities | 1.13 | 4.64 | 8.30 |
| 0.06 | 1.39 | 3.05 | |
| CWIP | 0.45 | 1.90 | 0.00 |
| Investments | 0.00 | 0.00 | 2.00 |
| 0.62 | 1.35 | 3.25 | |
| Total Assets | 1.13 | 4.64 | 8.30 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| 0.23 | 0.62 | 4.31 | |
| -0.06 | -2.81 | -2.52 | |
| 0.28 | 2.32 | -0.08 | |
| Net Cash Flow | 0.44 | 0.13 | 1.71 |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|
| Debtor Days | 0.00 | 20.28 | 0.85 |
| Inventory Days | 8.83 | 41.93 | 35.83 |
| Days Payable | 94.19 | 113.45 | 64.19 |
| Cash Conversion Cycle | -85.36 | -51.24 | -27.51 |
| Working Capital Days | -74.20 | -117.40 | -58.95 |
| ROCE % | 1.60% | 72.04% |
Documents
Announcements
No data available.
Annual reports
No data available.
Services Offered[1]
In-house Dialysis Unit
Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology
NABL accredited inhouse Pathology
Inhouse Pharmacy
Advance diagnostic facilities
Renal Nutrition department
Home Care
Mukti (Lifestyle Support Program)
Home Dialysis